Wegovy is also indicated for pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity)
Here, you dont need to administer per day injectables rather you have to administer semaglutide injection once a week
The efficacy gap is enormous
For challengers who face IPR institution uncertainty, the reexamination route provides an alternative pathway to affecting claim scope, even if it does not deliver the clean invalidity finding that a favorable final written decision provides
Ongoing supervision helps identify side effects and tolerance changes early
That is a trial average, not an individual promise results vary widely and depend on dose response, nutrition, and activity, and your plan is adjusted based on your actual response